Canterbury DHB

Context

Recombinant Factor VIII

Recombinant Factor VIII is available as either short half-life (Advate) or extended half-life (Adynovate), the Pharmac-reimbursed brands.

Current usage of recombinant products for factor VIII includes:

In This Section

Advate

Adynovate (extended half-life rFVIII)

Advate

Adynovate (extended half-life rFVIII)

About this Canterbury DHB document (5290):

Document Owner:

Not assigned (see Who's Who)

Last Reviewed:

November 2019

Next Review:

November 2022

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5290